Open Market Insiders Trades - Buys only
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- P - Open market or private purchase of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
NEM
|
Chris J Robison
EVP, COO |
BUY
Open market or private purchase
|
Direct | 4,494 Added 15.5% |
$105,924
$23.57 p/Share
|
Mar 26
2014 |
JEF
|
Stuart Harry Reese |
BUY
Open market or private purchase
|
Direct | 4,000 Added 50.0% |
$108,440
$27.11 p/Share
|
Mar 25
2014 |
ALNY
|
Sanofi
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 344,448 Added 3.64% |
$23,036,681
$66.88 p/Share
|
Mar 25
2014 |
REGN
|
Sanofi |
BUY
Open market or private purchase
|
Indirect | 306,945 Added 0.1% |
$94,140,035
$306.7 p/Share
|
Mar 24
2014 |
REGN
|
Sanofi |
BUY
Open market or private purchase
|
Indirect | 305,115 Added 0.08% |
$98,472,812
$322.74 p/Share
|
Mar 21
2014 |
NVDA
|
Ajay K Puri
EVP, Worldwide Field Ops |
BUY
Open market or private purchase
|
Direct | 114 Added 0.02% |
$2,147
$18.83 p/Share
|
Mar 21
2014 |
REGN
|
Sanofi |
BUY
Open market or private purchase
|
Indirect | 57,957 Added 0.08% |
$18,993,668
$327.72 p/Share
|
Mar 20
2014 |
REGN
|
Sanofi |
BUY
Open market or private purchase
|
Indirect | 9,746 Added 0.02% |
$3,192,497
$327.57 p/Share
|
Mar 19
2014 |
SPB
|
Jefferies Financial Group Inc. |
BUY
Open market or private purchase
|
Indirect | 23,000,000 Added 35.59% |
$253,000,000
$11.0 p/Share
|
Mar 18
2014 |
REGN
|
Sanofi |
BUY
Open market or private purchase
|
Indirect | 60,128 Added 0.17% |
$19,757,459
$328.59 p/Share
|
Mar 17
2014 |
V
|
Alfred F Kelly Jr
EXECUTIVE CHAIRMAN |
BUY
Open market or private purchase
|
Direct | 1,575 Added 50.0% |
$350,752
$222.7 p/Share
|
Mar 17
2014 |
EVRI
|
Juliet Lim
EVP |
BUY
Open market or private purchase
|
Direct | 5,000 Added 50.0% |
$40,500
$8.1 p/Share
|
Mar 14
2014 |
EVRI
|
Randy L Taylor
President & CEO |
BUY
Open market or private purchase
|
Direct | 5,000 Added 32.15% |
$40,500
$8.1 p/Share
|
Mar 14
2014 |
EVRI
|
Ram Chary
President & CEO |
BUY
Open market or private purchase
|
Direct | 15,000 Added 50.0% |
$121,050
$8.07 p/Share
|
Mar 14
2014 |
EVRI
|
Michael Scott Dowty
EVP |
BUY
Open market or private purchase
|
Direct | 10,000 Added 24.01% |
$80,600
$8.06 p/Share
|
Mar 14
2014 |
EVRI
|
Robert Myhre
EVP |
BUY
Open market or private purchase
|
Direct | 5,000 Added 10.59% |
$40,350
$8.07 p/Share
|
Mar 14
2014 |
EVRI
|
E Miles Kilburn
Director |
BUY
Open market or private purchase
|
Direct | 10,000 Added 7.48% |
$81,100
$8.11 p/Share
|
Mar 14
2014 |
REGN
|
Sanofi |
BUY
Open market or private purchase
|
Indirect | 55,583 Added 0.08% |
$18,230,113
$327.98 p/Share
|
Mar 14
2014 |
EVRI
|
David Lucchese
EVP, Sales and Marketing |
BUY
Open market or private purchase
|
Direct | 5,000 Added 6.05% |
$41,100
$8.22 p/Share
|
Mar 14
2014 |
REGN
|
Sanofi |
BUY
Open market or private purchase
|
Indirect | 220,995 Added 0.09% |
$73,445,477
$332.34 p/Share
|
Mar 12
2014 |
REGN
|
Sanofi |
BUY
Open market or private purchase
|
Indirect | 180,710 Added 0.13% |
$60,022,825
$332.15 p/Share
|
Mar 11
2014 |
REGN
|
Sanofi |
BUY
Open market or private purchase
|
Indirect | 199,822 Added 0.14% |
$65,719,461
$328.89 p/Share
|
Mar 10
2014 |
REGN
|
Sanofi |
BUY
Open market or private purchase
|
Indirect | 69,873 Added 0.02% |
$22,088,952
$316.13 p/Share
|
Mar 07
2014 |
REGN
|
Sanofi |
BUY
Open market or private purchase
|
Indirect | 241,818 Added 0.12% |
$80,646,303
$333.5 p/Share
|
Mar 07
2014 |
REGN
|
Sanofi |
BUY
Open market or private purchase
|
Indirect | 80,404 Added 0.23% |
$27,275,450
$339.23 p/Share
|
Mar 06
2014 |
KCG
|
Jefferies LLC |
BUY
Open market or private purchase
|
Direct | 6,000,000 Added 21.08% |
$66,000,000
$11.0 p/Share
|
Mar 03
2014 |
REGN
|
Sanofi |
BUY
Open market or private purchase
|
Indirect | 251,594 Added 0.13% |
$84,138,069
$334.42 p/Share
|
Mar 03
2014 |
DVA
|
Berkshire Hathaway Inc
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 422,247 Added 0.56% |
$28,556,563
$67.63 p/Share
|
Feb 26
2014 |
DVA
|
Berkshire Hathaway Inc
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 661,129 Added 0.87% |
$44,255,977
$66.94 p/Share
|
Feb 25
2014 |
DVA
|
Berkshire Hathaway Inc
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 76,482 Added 0.1% |
$5,170,948
$67.61 p/Share
|
Feb 24
2014 |
PM
|
Sergio Marchionne
Director |
BUY
Open market or private purchase
|
Direct | 1,000 Added 1.83% |
$79,700
$79.7 p/Share
|
Feb 21
2014 |
CVX
|
Robert E Denham
Director |
BUY
Open market or private purchase
|
Direct | 2,000 Added 5.24% |
$226,820
$113.41 p/Share
|
Feb 14
2014 |
MA
|
Martina Hundmejean
Chief Financial Officer |
BUY
Open market or private purchase
|
Indirect | 2 Added 0.1% |
$153
$76.46 p/Share
|
Feb 11
2014 |
REGN
|
Sanofi |
BUY
Open market or private purchase
|
Indirect | 21,986 Added 0.03% |
$6,315,039
$287.23 p/Share
|
Feb 07
2014 |
REGN
|
Sanofi |
BUY
Open market or private purchase
|
Indirect | 146,525 Added 0.15% |
$41,849,003
$285.61 p/Share
|
Feb 06
2014 |
BKGM
|
Agustin Joe Taitano San
Director |
BUY
Open market or private purchase
|
Direct | 5 Added 0.05% |
$45
$9.0 p/Share
|
Feb 05
2014 |
BKGM
|
Guerrero Martin Dela Rosa Leon
Director |
BUY
Open market or private purchase
|
Direct | 150 Added 0.23% |
$1,350
$9.0 p/Share
|
Feb 05
2014 |
BKGM
|
Guerrero Eugenia Aflague Leon
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 738 Added 0.04% |
$6,642
$9.0 p/Share
|
Feb 05
2014 |
BKGM
|
Luis Garcia Camacho
Director |
BUY
Open market or private purchase
|
Indirect | 385 Added 0.15% |
$3,465
$9.0 p/Share
|
Feb 05
2014 |
BKGM
|
Roger Powell Crouthamel
Director |
BUY
Open market or private purchase
|
Indirect | 217 Added 0.06% |
$1,953
$9.0 p/Share
|
Feb 05
2014 |
REGN
|
Sanofi |
BUY
Open market or private purchase
|
Indirect | 206,978 Added 0.09% |
$58,216,700
$281.27 p/Share
|
Feb 05
2014 |
RGLS
|
Sanofi
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 1,303,780 Added 20.51% |
$9,999,993
$7.67 p/Share
|
Feb 04
2014 |
REGN
|
Sanofi |
BUY
Open market or private purchase
|
Indirect | 190,286 Added 0.17% |
$54,246,730
$285.08 p/Share
|
Feb 04
2014 |
REGN
|
Sanofi |
BUY
Open market or private purchase
|
Indirect | 198,058 Added 0.11% |
$56,278,179
$284.15 p/Share
|
Feb 03
2014 |
REGN
|
Sanofi |
BUY
Open market or private purchase
|
Indirect | 10,914 Added 0.02% |
$3,144,651
$288.13 p/Share
|
Jan 31
2014 |
MS
|
Mitsubishi Ufj Financial Group Inc
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 0 Added 0.0% |
$0
$29.55 p/Share
|
Jan 31
2014 |
MEI
|
Timothy Glandon
Vice President |
BUY
Open market or private purchase
|
Direct | 8 Added 0.01% |
$274
$34.2 p/Share
|
Jan 31
2014 |
REGN
|
Sanofi |
BUY
Open market or private purchase
|
Indirect | 83,235 Added 0.09% |
$23,029,459
$276.68 p/Share
|
Jan 28
2014 |
REGN
|
Sanofi |
BUY
Open market or private purchase
|
Indirect | 74,685 Added 0.07% |
$20,365,105
$272.68 p/Share
|
Jan 27
2014 |
PLXS
|
Rainer Jueckstock
Director |
BUY
Open market or private purchase
|
Direct | 2,000 Added 50.0% |
$82,580
$41.29 p/Share
|
Jan 21
2014 |